Bruce Ross was elected to the board of directors of Princeton,N.J.-based Cytogen Corp. Ross recently retired as senior vicepresident of Bristol-Myers Squibb Co.'s Pharmaceutical Group.
Human Genome Sciences of Rockville, Md., appointed BradleyLorimier as its senior vice president for business development.Lorimier was vice president of commercial development atOrtho Pharmaceutical Co. of Johnson & Johnson.
Alteon Inc. has named James Mauzey as chief executive officer.Mauzey, who left his position as president of corporate hospitalaccounts at Bristol-Myers Squibb Co., will replace Charles Fadenin Alteon's top spot. Faden retired Dec. 31. Jere Goyan, who hadbeen acting CEO of the Northvale, N.J., company will remain asAlteon's president and chief operating officer.
Christoph Michael Adams has left his position as businessdevelopment manger of Ciba-Geigy's worldwidepharmaceuticals business to join Transkaryotic Therapies Inc.Adams is now vice president for business development of theCambridge, Mass., company, a newly created position.
(c) 1997 American Health Consultants. All rights reserved.